Genomics Shares Slide as Lehman Calls Sector Overvalued
The brokerage house points out that these companies are years from having actual profit-making products.
04:30PM 01/31/01
Pozen Plunges on Migraine Drug's Setback
Interactivity concerns prompt the FDA to push for more tests, analysts say.
05:08PM 01/26/01
Quiet on Claritin Replacement Disquiets Schering-Plough Investors
The FDA preliminarily backs desloratadine, but analysts wonder if the drug is on the slow track.
03:25PM 01/26/01
American Home in Fat City Even as Charge Swells
Investors bid up the stock after the company adds once more to its diet-drug litigation reserve.
01:56PM 01/25/01
Merck Profits Jump 14% as Drug Juggernaut Rolls
Sales of Zocor and Vioxx lead the way.
10:52AM 01/23/01
Biotech Stocks Rally as Amgen Prevails in Patent Case
A ruling against Transkaryotic ignites a 6% surge in biotech stocks.
12:42PM 01/22/01
Genentech Slides as Drug Setbacks Trim Optimism
The biotech has long delivered strong results, but recent developments have some observers concerned.
04:28PM 01/19/01
Genentech's Numbers Meet Expectations
The biotech firm cites strong sales of its leading cancer drugs.
05:44PM 01/18/01
Biogen Beats Estimates as Avonex Sales Rise
Sales of the biotech company's main product are 'reinvigorated.'
05:14PM 01/17/01
Shorts Salivate as Alexion Prepares Drug Data
Some investors think the company's enzyme numbers won't stand up to doctors' scrutiny.
09:59AM 01/17/01
Find more premium investing ideas